-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Avalo Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2016 to Q2 2025.
- Avalo Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2025 was -1.92 USD/shares, a 146% decline year-over-year.
- Avalo Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2025 was 125 USD/shares, a 33.5% increase year-over-year.
- Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -7.94 USD/shares, a 93% increase from 2023.
- Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -114 USD/shares.
- Avalo Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.06K USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)